References
- 1. Kebebew E, Clark OH. Differentiated thyroid cancer: “complete” rational approach. World J Surg 2000; 24: 942-51.
- 2. Caron NR, Clark OH. Well differentiated thyroid cancer. Scand J Surg 2004; 93: 261-71.
- 3. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-214.
- 4. Luster M, Lippi F, Jarzab B, et al. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Endocr Rel Canc 2005; 12: 49-64.
- 5. Duntas LH, Biondi B. Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. Eur J Endocrinol 2007; 156: 13-19.
- 6. Wu H, Zuo S, Ma C, et al. Short-term overt hypothyroidism affect on lipids after thyroxine-withdrawal in patients with differentiated thyroid carcinoma. Chinese- German J Clin Oncol 2009; 8: 647-9.
- 7. Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol 2005; 152: 355-61.
- 8. Prakash A, Lal AK. Serum lipids in hypothyroidism: our experience. Ind J Clin Biochem 2006; 21: 153-5.
- 9. Sunanda V, Sangeeta S, Prabhakar Rao B. Study of lipid profile in hypothyroidism. Int J Biol Med Res 2012; 3: 1373-6.
- 10. Luster M, Clarke SE, Dietlein M, et al. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2008; 35: 1941-59.
- 11. Ravishankar U, Pande S, Savita N. I-131 in the management of differentiated thyroid cancer - an update on current recommendations and practices. Apollo Med 2009; 6: 347-54.
- 12. Woodrum DT, Gauger PG. Role of 131I in the treatment of well differentiated thyroid cancer. J Surg Oncol 2005; 89: 114-21.
- 13. Vrachimis A, Schober O, Riemann B. Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation. Nuklearmedizin 2012; 51: 67-72.
- 14. Canaris GJ, Manowitz NR, Mayor G, Ridqway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-34.
- 15. Duntas LH. Thyroid disease and lipids. Thyroid 2002; 12: 287-93.
- 16. Pearce EN. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr Cardiol Rep 2004; 6: 451-6.
- 17. Regalbuto C, Alagona C, Maiorana R, et al. Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer. J Endocrinol Invest 2006; 29: 32-40.
- 18. Pucci E, Chiovalto L, Pinchera A. Thyroid and lipid metabolism. Int’l J Obesity 2004; 24: 109-12.
- 19. Saini V, Yadav A, Arora S, Singh R, Bhattacharjee J. Association between different degrees of hypothyroidism and serum lipids. Internet J Med Update 2012; 7: 3-8.
- 20. Regmi A, Shah B, Rai BR, Pandeya A. Serum lipid profile in patients with thyroid disorders in central Nepal. Nepal Med Coll J 2010; 12: 253-6.
- 21. Yilmaz IA, Akcay T, Cakatay U, Telci A, Ataus S, Yalcin VR. Relation between bladder and protein oxidation. Int Urol Nephrol 2003; 35: 345-50.
- 22. Chandran V, Anitha M, Avinash SS, Rao GM, Shetty BV, Sudha K. Protein oxidation: A potential cause of hypoalbuminemia in oral cancer. Biomed Res 2012; 23: 227-30.
- 23. Omur O, Akgun A, Ozcan Z, Sen C, and OzkiIic H. Clinical implications of diffuse hepatic uptake observed in postablative and post-therapeutic I-131 scans. Clin Nucl Med 2009;34: 11-14.
- 24. Kaysen GA, Jones H Jr, Joles JA, van Tol A. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis. Miner Electrolyte Metab. 1996;22:31-8.
- 25. O’Donnell MP. Mechanisms and clinical importance of hypertriglyceridemia in the nephrotic syndrome. Kidney Int 2001; 59: 380-2.
- 26. Obrenovic R, Petrovic D, Glišic B, Majkić-Singh N, Trbojevic J, Stojimirović B. Influence of proteinuria on disorders of lipoprotein metabolism. Jugoslov Med Biochem 2005, 24: 259-64.
- 27. Matsuda I, Maeda T, Takase A, Arashima S. Hyperlipidaemia during persistent peritoneal dialysis. Arch. Dis. Child 1972; 47: 139-40.
- 28. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94: 1 - 90.
- 29. Gälman C, Matasconi M, Persson L, Parini P, Angelin B, Rudling M. Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol. Am J Physiol Endocrinol Metab 2007; 293: E737-E742.
- 30. Gesing A, Lewiński A, Karbownik-Lewińska M. The thyroid gland and the process of aging; what is new? Thyroid Res 2012; 5: 16.
- 31. Bremner AP, Feddema P, Leedman PJ, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012; 97: 1554-62.